期刊文献+

复发性胸腺瘤的诊治进展 被引量:4

原文传递
导出
摘要 胸腺瘤是最常见的纵隔肿瘤,约占成人纵隔肿瘤的20%,通常生长缓慢,但具有侵袭和复发的特性,手术切除是胸腺瘤的主要治疗方式。据统计,胸腺瘤完全切除后复发率为5%~50%[1-3],平均复发时间为(34.6±25.7)个月[4],有15%的患者可能在术后10年甚至更长时间复发[5]。
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2014年第9期572-575,共4页 Chinese Journal of Thoracic and Cardiovascular Surgery
  • 相关文献

参考文献48

  • 1Ruffini E,Mancuso M,Oliaro A,et al.Recurrence of thymoma:analysis of clinicopathologic features,treatment,and outcome[J].J Thorac Cardiovasc Surg,1997,113:55-63.
  • 2Blumberg D,Port JL,Weksler B,et al.Thymoma:a multivariate analysis of factors predicting survival[J].Ann Thorac Surg,1995,60:908-913.
  • 3Bae MK,Lee CY,Lee JG,et al.Predictors of recurrence after thymoma resection[J].Yonsei Med J,2013,54:875-882.
  • 4Yano M,Sasaki H,Moriyama S,et al.Number of recurrent lesions is a prognostic factor in recurrent thymoma[J].Interact Cardiovasc Thorac Surg,2011,13:21-24.
  • 5Bae MK,Byun CS,Lee CY,et al.Clinical outcomes and prognosis of recurrent thymoma management[J].J Thorac Oncol,2012,7:1304-1314.
  • 6Huang J,Detterbeck FC,Wang Z,et al.Standard outcome measures for thymic malignancies[J].J Thorac Oncol,2011,6:S1691-1697.
  • 7Wright CD,Wain JC,Wong DR,et al.Predictors of recurrence in thymic tumors:importance of invasion,World Health Organization histology,and size[J].J Thorac Cardiovasc Surg,2005,130:1413-1421.
  • 8Regnard JF,Zinzindohoue F,Magdeleinat P,et al.Results of re-resection for recurrent thymomas[J].Ann Thorac Surg,1997,64:1593-1598.
  • 9Margaritora S,Cesario A,Cusumano G,et al.Single-centre 40-year results of redo operation for recurrent thymomas[J].Eur J Cardiothorac Surg,2011,40:894-900.
  • 10Okumura M,Shiono H,Inoue M,et al.Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to world health organization histologic classification system[J].J Surg Oncol,2007,95:40-44.

同被引文献27

  • 1姜功前,吉庆春,陈占军,宋静超,崔新征.22例重症肌无力合并胸腺瘤的手术治疗体会[J].中国实用神经疾病杂志,2010,13(23):28-29. 被引量:6
  • 2Forquer JA, Rong N, Fakiris A J, et al. Postoperative radiother- apy after surgical resection of thymoma., differing roles in local- ized and regional disease[J]. Int J Radiat Oncol Biol Phys, 2010,76(2) :440-445.
  • 3Nguyen- Tan PF, Zhang Q, Ang KK, et al. Randomized phase III trial to test accelerated versus standard fraefionation in combination with concurrent cisplatin for head and neck carci- nomas in the Radiation Therapy Oneology Group 0129 trial: long-term report of efficacy and toxieity[J]. J Clin Oncol, 2014,32(34) :3858-3866.
  • 4Gould MK. Clinical practice. Lung-cancer screening with low-dose computed tomography[ J]. N Engl J Med, 2014, 371 (19) : 1813- 1820. doi : 10. 1056/NEJMcp1404071.
  • 5Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: New bio- logical insights and recent therapeutic advances [ J]. CA Cancer J Clin, 2011, 61 (2) :91-112. doi :10. 3322/caac. 20102.
  • 6Jameson JL, Longo DL. Precision medicine-personalized, problemat- ic, and promising[ J ]. N Engl J Med, 2015, 372 (23) :2229-2234. doi : 10. 1056/NEJMsb1503104.
  • 7Cypel M, Yeung C, Liu M, et al. Nomlothermic ex vivo lung perfu- sion in clinical lung transplantation [J]. N Engl J Med, 2011 , 364 ( 15 ) : 1431-1440. doi : 10. 1056/NEJMoaI014597.
  • 8Kajstura J, Rota M, Hall SR, eta|. Evidence for human lung stem cells[J]. N Engl J Med, 2011, 364 (19) : 1795-1806. doi: 10. 1056/NEJMoa1101324.
  • 9Chao YK, Liu YH, Hsieh MJ, eta|. Long-term outcomes after thora- coscopic resection of stage 1 and II thymoma: a propensity-matched study[J]. Ann Surg Oncol, 2015, 22 (4) : 1371-1376. doi: 10. 1245/s10434-0144068-9.
  • 10Zare RN, Winnacker E. Chinas Science Funding [ J ]. Science, 2011, 334 (6055) :433. doi : 10.1126/science. 1214042.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部